17-Ph-trinor-PGE2,
17-phenyl-omega-trinor PGE2,
17-phenyltrinorprostaglandin E2,
17-phenyl-trinor-PGE2,
17-PHENYL TRINOR PROSTAGLANDIN E2,
17-phenyl-omega-trinor-PGE2,
17-phenyl-omega-trinor PGE2,
17-phenyl-omega-trinor-prostaglandin E2,
17-phenyltrinor-PGE2,
17-phenyl-trinor-prostaglandin E2,
17-phenyltrinor-prostaglandin E2,
38315-43-4,
17-phenyl-18,19,20-trinor-PGE2,
CL 116147,
17-phenyl-18,19,20-trinor-prostaglandin E2,
9-oxo-11R,15S-dihydroxy-17-phenyl-18,19,20-trinor-5Z,13E-prostadienoic acid,
(Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxy-5-phenylpent-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid,
17-Ph-trinor-PGE2,
17-Ph-omega-trinor-PGE2,
17-phenyltrinorprostaglandin E2,
PGE2,17-Phenyl,
AC1NR1GD,
17-phenyl trinor PGE2,
17-pt-PGE2,
BSPBio_001369,
BML2-B01,
GTPL1912,
SCHEMBL3367843,
17-Phenyl-trinor-PGE..2..,
CHEMBL1879970,
BDBM82094,
CHEBI:87820,
FOBVMYJQWZOGGJ-XYRJXBATSA-N,
HMS1361E11,
HMS1791E11,
HMS1989E11,
HMS3402E11,
HMS3648J13,
FA(23:5)(OH2,Ke,cyclo2),
1271AH,
LMFA03010067,
ZINC13815368,
IDI1_033839,
NCGC00161300-01,
NCGC00161300-02,
NCGC00161300-03,
CAS_38315-43-4,
Z-3298,
SR-01000946438,
SR-01000946438-1,
BRD-K90214371-001-02-0,
9-Oxo-11.alpha.,15S-dihydroxy-17-phenyl-18,19,20-trinor-prosta-5Z,13E-dien-1-oic acid,
(5Z)-7-{(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxy-5-phenylpent-1-en-1-yl]-5-oxocyclopentyl}hept-5-enoic acid,
17-phenyl-PGE2,
D0X2MQ,
Bio1_000800,
C23H30O5,
CID5283068,
C092396,